刘素香, 申彦, 孙保存. 端粒酶与凋亡相关蛋白在卵巢交界性肿瘤中的表达[J]. 中国肿瘤临床, 2004, 31(3): 149-152.
引用本文: 刘素香, 申彦, 孙保存. 端粒酶与凋亡相关蛋白在卵巢交界性肿瘤中的表达[J]. 中国肿瘤临床, 2004, 31(3): 149-152.
Liu Su-xiang, Shen Yan, Sun Baocun. Significance of Expression of hTERT and Apoptosis Related Protein (bcl-2 and caspase-3) in Borderline Epithelial Ovarian Tumors[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 31(3): 149-152.
Citation: Liu Su-xiang, Shen Yan, Sun Baocun. Significance of Expression of hTERT and Apoptosis Related Protein (bcl-2 and caspase-3) in Borderline Epithelial Ovarian Tumors[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 31(3): 149-152.

端粒酶与凋亡相关蛋白在卵巢交界性肿瘤中的表达

Significance of Expression of hTERT and Apoptosis Related Protein (bcl-2 and caspase-3) in Borderline Epithelial Ovarian Tumors

  • 摘要: 目的:探讨端粒酶蛋白亚单位(hTERT)与凋亡相关蛋白(bcl-2、caspase-3)在卵巢上皮性交界性肿瘤中的表达及临床意义。方法:选取天津市肿瘤医院病理科存档的卵巢上皮性交界性肿瘤41例,采用免疫组化SP法检测hTERT、bcl-2与caspase-3在肿瘤组织中的表达,与22例良性、30例恶性肿瘤进行比较,并探讨三者间表达的相关性。结果:1)hTERT在卵巢交界性肿瘤中阳性率为46.3%,而良性与恶性肿瘤分别为36.4%,73.3%,与交界性肿瘤相比,恶性肿瘤阳性率明显升高(P=0.023),而良性肿瘤与之的差异无统计学意义(P=0.446)。2)bcl-2和caspase-3在卵巢交界性肿瘤中阳性率为58.5%和73.2%,良性与恶性肿瘤分别为59.1%、72.7%和86.7%、43.3%,其中bcl-2的阳性率在交界性肿瘤中明显低于恶性肿瘤(P=0.010),caspase-3反之(P=0.011);但它们在交界性肿瘤中的表达无相关性(r=-0.063,P>0.05),且二者在交界性与良性肿瘤间的差异无统计学意义(P=0.966,0.970)。3)对93例卵巢肿瘤研究发现,hTERT与bcl-2蛋白表达无相关性(r=0.037,P>0.05);hTERT与caspase-3表达呈显著负相关(χ2=4.8109,r=-0.227,P<0.05)。结论:hTERT蛋白表达可以反映端粒酶活性与hTERTmRNA水平,与凋亡相关蛋白(bcl-2、caspase-3)的联合检测可进一步判断卵巢交界性肿瘤良恶性,有望成为识别卵巢交界性肿瘤中高危人群的标志物。

     

    Abstract: Objective :To study the significance of expression of the catalytic subunit ofhuman telomerase hTERT and apoptosis related protein (bcl-2, casperse-3) in borderline epithelialovarian tumors. Meth-ods :Forty-one cuses of borderline epithelial ovarian tumors were studiedwhich were admitted to the Tianjin Cancer Institute and Hospital. hTERT, bcl-2 and casperse-3were analyzed using immunohistochemistry in formalin-fixed paraffin-embedded tissue. Their statuswere compared to twenty-two benign and thirty malignant tumors. Results :(1) Of the borderlineovarian tumors, the positive expression rate of hTERT was 46.3% which was significantly lowerthan those of malignant(73.3%)tumors ( P=0.023), but the difference between the borderline andbenign ovarian tumors was not significant (P=0.446).(2) Of the borderline ovarian tumors, the positive expression rate of bcl-2 and casperse-3 was 58.5%and 73.2%, while in the benign andmalignant tumors was 59.1%and 72.7%, 86.7% and 43.3%, respectively. Compared to borerlinetumors ,the expression rate of bcl-2 and casperse-3 in malignant tumors was significantly higheror lower(P=0.010, 0.011), but there was no correlation between expressions of bcl-2 and casperse-3in borderline ovarian tumors(r=-0.063, P>0.05).And the differences of them between benign and borderline tumors were not signifieant CP=0.966, 0.970). (3) Of the ninety-threeovanan tumors,there was no correlation between expressions of hTERT and bcl-2(r=0.037, P>0.05):but therewas significantly reverse correlation between expressions of hTERT and casperse-3 (r=-0.227, P<0.05). Conclusion :These data suggest that detecting hTERT may reflect elomerase activity andthe level of hTERTmRNA,co-examination of hTERT and apoptosis related protein (bcl-2 and casperse-3) may contribute to estimating the malignant potential of borderline ovarian tumors. Sothey possibly become new markers to distinguish a subpopulation with the potential to develop invasive carcinomas.

     

/

返回文章
返回